Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (13,815)	$ (7,940)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,605	2,090
Other debt related costs included in interest expense	1,069	1,997
Termination fees included in payoff of 2013 Loan and Security Agreement	0	277
Provision for bad debt expense	71	143
Share-based compensation expense	605	548
Expense for issuance of warrant to SWK in connection with debt amendment	361	0
Expense for common stock issuance for payment of transaction costs for the Merger	364	0
Expense for issuance of common stock and payment of transaction costs in connection with debt	0	50
Write-off of SWK Warrant 2	0	(887)
Change in assets and liabilities:
Accounts receivable	(4,999)	(1,981)
Inventories	(622)	(914)
Other assets	(473)	(132)
Accounts payable, accrued expenses and other liabilities	3,259	(332)
Net cash used in operating activities	(11,543)	(7,081)
Cash flows from investing activities:
Capital expenditures	(204)	(287)
Cash acquired from Merger with Provant Health Solutions	1,936	0
Net cash provided by (used in) investing activities	1,732	(287)
Cash flows from financing activities:
Payments under credit facilities	(26,569)	(23,563)
Principal payments on Term Loan	0	(954)
Proceeds from amendments of Term Loan	4,783	0
Issuance of common stock and warrants, net of issuance costs	3,414	6,183
Payments on capital lease obligations	(160)	0
Debt issuance costs	0	(36)
Net cash provided by financing activities	9,535	6,158
Net decrease in cash and cash equivalents	(276)	(1,210)
Cash and cash equivalents at beginning of period	1,866	2,035
Cash and cash equivalents at end of period	1,590	825
Supplemental disclosure of non-cash investing and financing activities:
Fixed assets vouchered but not paid	185	94
Fair value of common stock issued as Merger consideration	6,792	0
Fair value of debt assumed in the Merger	7,110	0
Issuance of common stock in connection with Second Amendment to Credit Agreement	0	100
Payoff of 2013 Loan and Security Agreement by SCM	0	(2,552)
Opening outstanding borrowings under 2016 Credit and Security Agreement	0	3,028
Non-cash debt issuance costs	0	550
Supplemental disclosure of cash paid during period for:
Income taxes	26	31
Interest	896	533
Provant
Cash flows from financing activities:
Payments under credit facilities	(4,684)	0
LPC Equity Line
Adjustments to reconcile net loss to net cash used in operating activities:
Expense for issuance of common stock and payment of transaction costs in connection with debt	32	0
2016 Credit and Security Agreement
Cash flows from financing activities:
Borrowings under credit facilities	30,751	24,528
Seasonal Facility
Cash flows from financing activities:
Borrowings under credit facilities	$ 2,000	$ 0